Vera Therapeutics, Inc. (VERA)

Vera Therapeutics Statistics

Total Valuation

VERA has a market cap or net worth of $1.89 billion. The enterprise value is $1.41 billion.

Market Cap	1.89B
Enterprise Value	1.41B

Important Dates

The next estimated earnings date is Friday, November 7, 2025, before market open.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	n/a

Share Statistics

VERA has 63.82 million shares outstanding. The number of shares has increased by 24.94% in one year.

Current Share Class	63.82M
Shares Outstanding	63.82M
Shares Change (YoY)	+24.94%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	0.82%
Owned by Institutions (%)	83.16%
Float	44.83M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.04
P/TBV Ratio	4.04
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 17.03, with a Debt / Equity ratio of 0.17.

Current Ratio	17.03
Quick Ratio	16.72
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-31.58

Financial Efficiency

Return on equity (ROE) is -54.83% and return on invested capital (ROIC) is -31.85%.

Return on Equity (ROE)	-54.83%
Return on Assets (ROA)	-30.24%
Return on Invested Capital (ROIC)	-31.85%
Return on Capital Employed (ROCE)	-43.31%
Revenue Per Employee	n/a
Profits Per Employee	-$1.95M
Employee Count	112
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, VERA has paid $1,000 in taxes.

Income Tax	1,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -30.95% in the last 52 weeks. The beta is 1.23, so VERA's price volatility has been higher than the market average.

Beta (5Y)	1.23
52-Week Price Change	-30.95%
50-Day Moving Average	26.96
200-Day Moving Average	25.73
Relative Strength Index (RSI)	53.83
Average Volume (20 Days)	1,094,289

Short Selling Information

The latest short interest is 9.76 million, so 15.29% of the outstanding shares have been sold short.

Short Interest	9.76M
Short Previous Month	9.94M
Short % of Shares Out	15.29%
Short % of Float	21.76%
Short Ratio (days to cover)	6.91

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-236.05M
Pretax Income	-218.28M
Net Income	-218.28M
EBITDA	-235.77M
EBIT	-236.05M
Earnings Per Share (EPS)	-$3.59

Balance Sheet

The company has $556.83 million in cash and $77.55 million in debt, giving a net cash position of $479.28 million or $7.51 per share.

Cash & Cash Equivalents	556.83M
Total Debt	77.55M
Net Cash	479.28M
Net Cash Per Share	$7.51
Equity (Book Value)	468.28M
Book Value Per Share	7.34
Working Capital	537.80M

Cash Flow

In the last 12 months, operating cash flow was -$185.27 million and capital expenditures -$1.28 million, giving a free cash flow of -$186.55 million.

Operating Cash Flow	-185.27M
Capital Expenditures	-1.28M
Free Cash Flow	-186.55M
FCF Per Share	-$2.92

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

VERA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.94%
Shareholder Yield	-24.94%
Earnings Yield	-11.53%
FCF Yield	-9.85%

Analyst Forecast

The average price target for VERA is $62.25, which is 110.66% higher than the current price. The consensus rating is "Buy".

Price Target	$62.25
Price Target Difference	110.66%
Analyst Consensus	Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1